NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.
The FDA is proposing a rule to require standardized asbestos testing in talc-containing cosmetics, aiming to reduce health risks linked to asbestos exposure. Johnson & Johnson is facing lawsuits related to asbestos-contaminated talc, while the FDA seeks input on the proposed rule from healthcare professionals and the public.
Reuters
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
2023 brought record-breaking heat waves in the United States, significantly impacting vulnerable groups. Analysis by the CDC revealed a substantial number of heat-related illness (HRI) emergency department visits, resulting in multiple public health alerts.
The FDA has approved pivmecillinam (Pivya) as a new treatment for uncomplicated urinary tract infections in women, offering an effective option for this common and debilitating condition.